Institutional investors purchased a net $2.3 million shares of SGYP during the quarter ended December 2012. This may signal that the smart money is gaining interest in this company as the 16.50% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
| Mutual fund holders | 8.58% |
| Other institutional | 7.92% |
| Individual stakeholders | 1.68% |